Synthesis and antitumor activity of some novel heterocyclic compounds derived from chalcone analogues

dc.AffiliationOctober University for modern sciences and Arts (MSA)
dc.contributor.authorM. El-Masry, Rana
dc.contributor.authorM. Kandeel, Manal
dc.contributor.authorA. Abdou, Nadia
dc.contributor.authorH. Kadry, Hanan
dc.date.accessioned2019-11-04T11:07:31Z
dc.date.available2019-11-04T11:07:31Z
dc.date.issued2014
dc.descriptionMSA Google Scholar
dc.description.abstractA series of chalcones (3a-c) was synthesized and cyclocondensed with hydrazine hydrate, hydroxylamine, urea and thiourea to afford novel pyrazoline (4a-c), (5a-c), isoxazoline (6), dihyrdopyrimidinone (7a, b) and dihyrdopyrimidinethione (8a, b) derivativesrespectively. In addition, a new barbiturate (9) and thiobarbiturate (10) derivatives were synthesized by reaction of chalcone derivatives with barbituric and thiobarbituric acid. Also, the novel pyrazolyl chalcone (13) was synthesized, reacted with hydrazine hydrate in ethanol and acetic acid respectively, to afford new pyrazoline derivative (14) and its N-acetyl derivative (15). Twelve of the synthesized derivatives were selected by NCI to be evaluated for their antitumor activity by in-vitro disease-oriented human cellsscreening panel assay. All the tested compounds exhibited a broad spectrum of antitumor activity especially against renal cancer UO-31. Compound (5c)is considered to be the most active member identified in thisstudy with a broad spectrum of activity against most cell lines.en_US
dc.description.sponsorshipOrg Chem Ind J (OCAIJ)en_US
dc.identifier.citation[1] J.B.Gibbs; Science, http://doi:10.1126/sci- ence.287.5460.1969, 287, 1969 (2000). [2] P.Heffeter, M.A.Jakupec, W.Orner, S.Wild, N.G.Keyserlingk, L.Elbling, H.Zorbas, A.Korynevska, S.Knasmuller, H.Sutterluty, M.Micksche, B.K.Keppler, W.Berger; Biochem.Pharmacol., http://dx.doi.org/10.1016/ j.bcp.2005.11.009, 71, 426 (2006). [3] (a) L.U.Charles, R.Komaki, J.S.Lee, D.M.Shin, J.L.Palmer, B.J.Coldman, K.M.Pisters,J.M.Kurie, F.V.Fossella,B.S.Glisson;Clin.Cancer Res., 9, 2085 (2003); (b) G.F.Fleming,J.W.Kugler, P.C.Hoffman, R.Ansari, J.D.Bitran, A.Klepsch, D.Malone, A.A.Fasanmade, M.J.Ratain, E.E.Vokes; J.Clin Oncology, 16, 2032 (1998). [4] H.P.Avila,E.F.A.Smania, F.D.Monache,A.S.Junior; Bioorg.Med.Chem., http://dx.doi.org/10.1016/ j.bmc.2008.09.064, 16, 9790 (2008). [5] (a) A.Modzelewska, C.Pettit, G.Achanta, N.E.Davidson, P.Huang, S.R.Khan; Bioorg.Med.Chem., http://dx.doi.org/10.1016/ j.bmc.2006.01.003, 14, 3491 (2006); (b) R.J.Anto, K.Sukumaran, G.Kuttana, M.N.A.Rao, V.Subbaraju, R.Kuttana; Cancer Lett., http:// dx.doi.org/10.1016/0304-3835(95)03945-S, 97, 33 (1995); (c) Y.L.Hsu, P.L.Kuo,W.S.Tzeng,C.C.Lin; Food Chem.Toxicol., http://dx.doi.org/10.1016/ j.fct.2005.10.003, 44, 704 (2006); (d) N.J.Lawrence, R.P.Patterson, L.L.Ooi, D.Cook, Hanan H.Kadry et al. 307 Full Paper OCAIJ, 10(8) 2014 Organic CHEMISTRY An Indian Journal S.Ducki; Bioorg.Med.Chem.Lett., http://dx.doi.org/ 10.1016/j.bmcl.2006.08.065, 16, 5844 (2006). [6] A.Valla, B.Valla, D.Cartier, R.L.Guillou, R.Labia, L.Florent; Eur.J.Med.Chem., http://dx.doi.org/ 10.1016/j.ejmech.2005.05.008, 41, 142 (2006). [7] S.F.Nielsen, S.B.Christensen, G.Cruciani, A.Kharazmi,T.Liljefors;J.Med.Chem., http://dx.doi: 10.1021/jm980410m, 41, 4819 (1998). [8] S.H.Lee, G.S.Seo, J.Y.Kim, X.Y.Jin, H.D.Kim, D.H.Sohn; Eur.J.Pharmacol., http://dx.doi.org/ 10.1016/j.ejphar.2006.01.005, 532, 178 (2006). [9] S.Cheenpracha, C.Karalai, C.Ponglimanont, S.Subhadhirasakul, S.Tewtrakul; Bioorg.Med. Chem., http://dx.doi.org/10.1016/j.bmc.2005.10.019, 14, 1710 (2006). [10] L.Svetaz, A.Tapia, S.N.Lopez, R.L.E.Furlan, E.Petenatti, R.Pioli; J.Agric.Food.Chem., http:// dx.doi:10.1021/jf035213x, 52, 3297 (2004). [11] O.Nerya, R.Musa, S.Khatib, S.Tamir,J.Vaya, Phytochemistry, http://dx.doi.org/10.1016/ j.phytochem.2004.04.016, 65, 1389 (2004). [12] Q.C.Meng, L.Ni, K.J.Worsencroft, J.Ye, M.D.Weingarten, J.M.Simpson, J.W.Skudlarek, E.M.Marino, K.Suen, C.Kunsch, A.Souder, R.B.Howard, C.L.Sundell, M.A.Wasserman, J.A.Sikorski;J.Med.Chem., http://dx.doi.10.1021/ jm0614230, 50, 1304 (2007). [13] K.Manna, Y.K.Agrawal; Bioorg.Med.Chem.Lett., http://dx.doi.org/10.1016/j.bmcl.2009.03.161, 19, 2688 (2009). [14] M.Abid, A.R.Bhat, F.Athar, A.Azam; Eur.J.Med.Chem., http://dx.doi..org/10.1016/ j.ejmech.2007.10.032, 44, 417 (2009). [15] Z.A.Kaplancikli, G.Turan-Zitouni, A.÷zdemir, O.D.Can, P.Chevallet; Eur.J.Med.Chem., http:// dx.doi.org/10.1016/j.ejmech.2008.09.002, 44, 2606 (2009). [16] D.Havrylyuk, B.Zimenkovsky, O.Vasylenko, L.Zaprutko, R.Lesyk; Eur.J.Med.Chem., http:// dx.doi.org/10.1016/j.ejmech.2008.09.032, 44,1396 (2009). [17] O.M.Khalil, H.M.Refaat; Orient.J.Chem., 27(4), 1581 (2011). [18] J.Easmon, G.Purstinger, G.Heinisch, T.Roth, H.H.Fiebig, W.Holzer, W.J‰ger, M.Jenny, J.Hofmann; J.Med.Chem., http://dx.doi:10.1021/ jm000979z, 44, 2164 (2001). [19] Y.Dai, K.Hartandi, Z.Ji, A.A.Ahmed, D.H.Albert, J.L.Bauch, J.J.Bouska, P.F.Bousquet, G.A.Cunha, K.B.Glaser, C.M.Harris, D.Hickman, J.Guo, J.Li, P.A.Marcotte, K.C.Marsh, M.D.Moskey, R.L.Martin, A.M.Olson, D.J.Osterling, L.J.Pease, N.B.Soni, K.D.Stewart, V.S.Stoll, P.Tapang, D.R.Reuter, S.K.Davidsen, M.R.Michaelides; J.Med.Chem., http://dx.doi. 10.1021/jm061280h, 50, 1584 (2007). [20] (a) S.J.Tangeda, A.Garlapati; Eur.J.Med.Chem., http://dx.doi:org/10.1016/j.ejmech. 2009.12.050, 45, 1453 (2010); (b) C.Mugnaini, E.Petricci, M.Botta, F.Corelli, P.Mastromarino, G.Giorgi; Eur.J.Med.Chem., http://dx.doi.org/10.1016/ j.ejmech.2006.09.002, 42, 256 (2007); (c) D.Raffa, M.C.Edler, G.Daidone, B.Maggio, M.Merickech, S.Plescia, D.Schillaci, R.Bai; Eur.J.Med.Chem., http://dx.doi.org/10.1016/j.ejmech.2003.12.009, 39, 299 (2004). [21] S.Zhu, S.Ji, X.Su, C.Sun, Y.Liu; Tetrahedron Lett., http://dx.doi.org/10.1016/j.tetlet.2008.01.054, 49, 1777 (2008). [22] M.M.Kandeel, N.A.Abdou, H.H.Kadry, R.M.El- Masry; Int.J.Chem.Tech.Res., 5, 401 (2013). [23] D.Kumar, N.M.Kumar, K.Akamatsu, E.Kusaka, H.Harada, T.Ito; Bioorg.Med.Chem.Lett., http:// dx.doi:10.1016/j.bmcl.2010.05.016, 20, 3916 (2010). [24] M.N.Bhatia, K.Mahadik; Sci.Pharma., http:// dx.doi:10.3797/scipharm.0803-36, 76, 259 (2008). [25] S.C.Shetty, V.C.Bhagat; Asian J.Chem., 20, 5037 (2008). [26] (a) M.R.Grever, S.A.Schepartz, B.A.Chabner; Semin.Oncol., 19, 622 (1992); (b) A.Monks, D.Scudiero, P.Skehan; J.Natl.Cancer Inst., 83, 757 (1991); (c) M.R.Boyd, K.D.Paull; Drug Dev.Res., http://dx.doi.org/10.1002/ddr.430340203, 34, 91 (1995); (d) P.Skehan, R.Storeng, D.Scudiero, A.Monks, J.McMahon, D.Vistica, J.R.Warren, H.Bokesch, S.Kenney, M.R.Boyd; J.Natl.Cancer Inst., http://dx.doi.org/10.1093/jnci/82.13.1107, 82, 1107 (1990). [27] M.Amir, S.A.Javed, H.Kumar; Med.Chem.Res., http://dx.doi:10.1007/s00044-009-9194-8, 19, 299 (2010). [28] N.M.A.El-Gawad; Bull.Fac.Pharm.Cairo Univ., 37, 47 (1999). [29] A.N.Osman, A.A.El-Gendy, M.M.Kandeel, E.M.Ahmad, H.A.A.El-Latif; Bull.Fac.Pharm. Cairo Univ., 41, 51 (2003). [30] F.A.Omran, R.M.Mohareb, A.A.El-Khair; Mol- ecules, 16, 6129 (2011).en_US
dc.identifier.doihttps://doi.org/
dc.identifier.issn0974 - 7516
dc.identifier.otherhttps://doi.org/
dc.identifier.urihttps://t.ly/g7g69
dc.language.isoenen_US
dc.publisherOrg Chem Ind J (OCAIJ)en_US
dc.relation.ispartofseriesOCAIJ;10(8), 2014 [295-307
dc.subjectUniversity ofen_US
dc.titleSynthesis and antitumor activity of some novel heterocyclic compounds derived from chalcone analoguesen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
avatar_scholar_256.png
Size:
6.31 KB
Format:
Portable Network Graphics
Description:
Loading...
Thumbnail Image
Name:
Ereprint_OCAIJ_1152.pdf
Size:
457.05 KB
Format:
Adobe Portable Document Format
Description: